Profound Medical Exceeds Q3 Revenue Estimates By 45%
Profound Medical anticipates Q3-2026 revenue of $9.8 million to $10 million, up ~300% and ~89% from previous periods. The announcement exceeds analyst consensus and is expected to drive stock interest.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed